What are the Treatment Options for Acute Myeloid Leukemia?
What are the Treatment Options for Acute Myeloid Leukemia?
Exploring Treatments
Treating Acute Myeloid Leukemia (AML) involves several strategies. Let's dive into the common therapies available.
Contents
- Induction Therapy
- Consolidation Therapy
- Targeted Therapy
Induction Therapy
Induction therapy is the first phase of AML treatment aimed at achieving remission. This often involves chemotherapy to kill as many leukemia cells as possible. The goal is to reduce the number of cancer cells to undetectable levels.
Consolidation Therapy
Once remission is achieved, consolidation therapy follows to eliminate any remaining leukemia cells. This phase uses higher doses of chemotherapy or potentially a stem cell transplant to prevent relapse.
Targeted Therapy
Targeted therapies use drugs that specifically attack cancer cell mutations. These therapies are chosen based on genetic testing results and can be more effective with fewer side effects than traditional chemotherapy.
FAQs
What is induction therapy?
Induction therapy is the initial treatment phase to achieve remission.
Why is consolidation therapy important?
It aims to destroy any remaining leukemia cells post-remission.
How does targeted therapy work?
It targets specific cancer cell mutations for more precise treatment.
Treatment Insights
Choosing the right treatment path is vital for managing AML effectively.
Additional References
- Döhner H, Wei AH, Appelbaum FR, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood 2022; 140:1345.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic.